Treatment of severe proliferative retinopathy and diabetic maculopathy.
Strict blood glucose control, early detection and surveillance of diabetic retinopathy by means of validated screening programmes, and judicious use of laser photocoagulation can greatly reduce the risk of visual loss in diabetes. Some patients however, have aggressive neovascular disease resistant to laser treatment, or present at a late stage with advanced fibroproliferative disease, and may progress rapidly to blindness. In the elderly with Type 2 disease, diabetic maculopathy is more common and requires a different therapeutic approach. The present article describes two diabetic patients and discusses the management of patients with severe proliferative retinopathy or diabetic maculopathy.
Ooi
C G
CG
Department of Diabetes and Endocrinology, Whiston Hospital, Prescot, Merseyside L35 5DR, UK.
Hardy
K J
KJ
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000601:surgery / Q000628:therapy*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D012160:Retina / Q000473:pathology; D014821:Vitrectomy